| 摘要 |
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4 - tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3, 4- tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4- dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is also disclosed. The process includes the preparation of all four isomers of N-~4-(3,4- dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-yl~formamide, which are also useful.
|
